Brandjackers grow online

The brandjacking of popular medicines is on the rise, according to MarkMonitor's Brandjacking Index. The latest edition finds that online pharmacies have increased their market footprint to $11 billion in sales in 2009, up from an estimated $4 billion in 2007. Article

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.